J. Jackson

发表

Bacterial Sport-Related Skin and Soft-Tissue Infections (SSTIs): An Ongoing Problem Among a Diverse Range of Athletes.

Justin J. Mitchell, Steven B. Singleton, A. Anwar, 2017, JBJS reviews.

J. Jackson, 2006, Seminars in cutaneous medicine and surgery.

Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema

J. Fowler, M. Jarratt, T. Jones, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis

J. Callen, J. Jackson, Tamella B Cassis, 2006, International journal of dermatology.

The spectrum of nephrocutaneous diseases and associations: Genetic causes of nephrocutaneous disease.

A. Kimball, A. Menter, A. Fenves, 2016, Journal of the American Academy of Dermatology.

The spectrum of nephrocutaneous diseases and associations: Inflammatory and medication-related nephrocutaneous associations.

A. Kimball, A. Menter, A. Fenves, 2016, Journal of the American Academy of Dermatology.

Defining treatment success in rosacea as ‘clear’ may provide multiple patient benefits: results of a pooled analysis

M. Schaller, Jerry Tan, N. Kerrouche, 2017, The Journal of dermatological treatment.

TNF- alpha inhibitors.

J. Jackson, 2007, Dermatologic therapy.

TNF-α inhibitors

J. Jackson, 2007 .

The role of brimonidine tartrate gel in the treatment of rosacea

Sandra M. Johnson, J. Minni, J. Jackson, 2015, Clinical, cosmetic and investigational dermatology.

Pyoderma gangrenosum: an update.

J. Callen, J. Jackson, Jeffrey P. Callen, 2007, Rheumatic diseases clinics of North America.

Inflammatory nephrocutaneous diseases including associated cutaneous and renal manifestations and referral considerations Disease Cutaneous findings Renal findings

A. Kimball, A. Menter, A. Fenves, 2016 .

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.

A. Fleischer, Z. Draelos, M. Steinhoff, 2014, Journal of drugs in dermatology : JDD.

A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40 mg modified-release capsules versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.

M. Schaller, M. Gooderham, L. Kemény, 2020, Journal of the American Academy of Dermatology.

Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea.

D. Lorenz, L. Kircik, J. Jackson, 2013, Journal of drugs in dermatology : JDD.

Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection.

J. Callen, J. Jackson, 1998, Journal of the American Academy of Dermatology.

Psoriasis, psoriatic arthritis and the possible association with Sjögren's syndrome

S. Rogers, P. Collins, B. McCartan, 1992, The British journal of dermatology.

Symmetric polyarthritis with livedo reticularis: a newly recognized manifestation of hepatitis C virus infection.

J. Callen, J. Jackson, C. Shearer, 1997, Journal of the American Academy of Dermatology.

DFD-01 Reduces Transepidermal Water Loss and Improves Skin Hydration and Flexibility

G. Grove, K. Allenby, J. Jackson, 2017, Dermatology and Therapy.

Methyldibromoglutaronitrile (Euxyl K400): a new and important sensitizer in the United States?

J. Fowler, J. Jackson, 1997, Journal of the American Academy of Dermatology.

Pyoderma Gangrenosum and IgA Myeloma

J. Jackson, J. Collen, 1997 .

Pyoderma gangrenosum: an expert commentary

J. Callen, J. Jackson, Jeffrey P. Callen, 2006 .

Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept.

N. Lowe, P. Yamauchi, Vivian Gindi, 2006, Journal of the American Academy of Dermatology.

Hepatitis C and the skin.

J. Jackson, J.Mark Jackson, 2002, Dermatologic clinics.

Case reports of etanercept in inflammatory dermatoses.

R. Norman, R. G. Greenberg, J. Jackson, 2006, Journal of the American Academy of Dermatology.

Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL.

M. Lebwohl, K. Duffin, L. Stein Gold, 2018, Journal of drugs in dermatology : JDD.

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study.

B. Strober, M. Lebwohl, K. Callis Duffin, 2017, Journal of drugs in dermatology : JDD.

Efficacy and Safety of Apremilast in Patients with Moderate Plaque Psoriasis with Lower BSA (UNVEIL Phase IV Study)

B. Strober, M. Lebwohl, K. Duffin, 2017 .

Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension

R. Kirsner, J. Silverberg, G. Friedman, 2023, Dermatology and Therapy.

A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris.

J. Almekinder, J. Jackson, J. J. Fu, 2010, Journal of drugs in dermatology : JDD.

Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients.

D. Lorenz, J. Callen, J. Fowler, 2010, Journal of drugs in dermatology : JDD.

Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance.

M. Pelle, J. Jackson, 2011, Journal of drugs in dermatology : JDD.

Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial.

A. Kimball, H. A. Xia, E. Boh, 2007, Journal of drugs in dermatology : JDD.

Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea.

M. Steinhoff, J. Fowler, T. Jones, 2014, Journal of drugs in dermatology : JDD.

Evaluation of a First-in-Class Proteasome Inhibitor in Patients With Moderate to Severe Rosacea.

J. Arbiser, J. Jackson, R. Coulon, 2021, Journal of Drugs in Dermatology.

Optimizing the use of topical brimonidine in rosacea management: panel recommendations.

F. Kerdel, E. Tanghetti, A. Hinek, 2015, Journal of drugs in dermatology : JDD.